Recombinant long-acting glyco PEGylated factor IX (nonacog beta pegol) in haemophilia B: assessment of target joints in multinational phase 3 clinical trials.
Saved in:
| Title: | Recombinant long-acting glyco PEGylated factor IX (nonacog beta pegol) in haemophilia B: assessment of target joints in multinational phase 3 clinical trials. |
|---|---|
| Authors: | Negrier, C.1, Young, G.2, Abdul Karim, F.3, Collins, P. W.4, Hanabusa, H.5, Colberg, T.6, Goldman, B.7, Walsh, C. E.8 |
| Source: | Haemophilia. Jul2016, Vol. 22 Issue 4, p507-513. 7p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 13518216 |
|---|---|
| DOI: | 10.1111/hae.12902 |
